Search Results - "TANZARELLA, Silvia"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    Dendritic Cells Acquire the MAGE-3 Human Tumor Antigen from Apoptotic Cells and Induce a Class I-Restricted T Cell Response by Russo, Vincenzo, Tanzarella, Silvia, Dalerba, Piero, Rigatti, Donata, Rovere, Patrizia, Villa, Antonello, Bordignon, Claudio, Traversari, Catia

    “…In an attempt to transduce monocyte-derived dendritic cells (DCs) with a retroviral vector coding for an intracytoplasmic tumor antigen (TAA), we were…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Identification of a promiscuous T-cell epitope encoded by multiple members of the MAGE family by TANZARELLA, S, RUSSO, V, LIONELLO, I, DALERBA, P, RIGATTI, D, BORDIGNON, C, TRAVERSARI, C

    Published in Cancer research (Chicago, Ill.) (01-06-1999)
    “…One of the major limitations of tumor-specific vaccination is the generation of antigen-loss variants that are able to escape the immune response elicited by a…”
    Get full text
    Journal Article
  5. 5

    Rhabdomyosarcomas are potential target of MAGE-specific immunotherapies by TANZARELLA, Silvia, LIONELLO, Ilaria, VALENTINIS, Barbara, RUSSO, Vincenzo, LOLLINI, Pier-Luigi, TRAVERSARI, Catia

    Published in Cancer Immunology, Immunotherapy (01-06-2004)
    “…The search for alternative strategies of therapy remains a major issue for most neoplastic diseases. The expression of several tumor antigens makes human…”
    Get full text
    Journal Article
  6. 6

    Multiple HLA-A alleles can present an immunodominant peptide of the human melanoma antigen Melan-A/MART-1 to a peptide-specific HLA-A0201+ cytotoxic T cell line by Fleischhauer, K, Tanzarella, S, Wallny, HJ, Bordignon, C, Traversari, C

    Published in The Journal of immunology (1950) (15-07-1996)
    “…The majority of HLA-A*0201-restricted tumor-infiltrating lymphocytes from melanoma patients recognize a peptide, MT(27-35), derived from the Melan-A/MART-1 Ag…”
    Get full text
    Journal Article
  7. 7

    Functional heterogeneity of HLA-A02 subtypes revealed by presentation of a MAGE-3-encoded peptide to cytotoxic T cell clones by Fleischhauer, K, Tanzarella, S, Russo, V, Sensi, ML, van der Bruggen, P, Bordignon, C, Traversari, C

    Published in The Journal of immunology (1950) (01-09-1997)
    “…The peptide-binding and presentation characteristics of seven naturally occurring HLA-A2 subtypes were studied using M3(271), a peptide derived from the…”
    Get full text
    Journal Article
  8. 8

    Rexpression of HLA class I antigens and restoration of antigen‐specific CTL response in melanoma cells following 5‐aza‐2′‐deoxycytidine treatment by Serrano, Alfonso, Tanzarella, Silvia, Lionello, Ilaria, Mendez, Rosa, Traversari, Catia, Ruiz‐Cabello, Francisco, Garrido, Federico

    Published in International journal of cancer (15-10-2001)
    “…Cell surface expression of HLA class I/peptide complexes on tumor cells is a key step in the generation of T‐cell‐based immune responses. Several genetic…”
    Get full text
    Journal Article
  9. 9

    Characterization of antigenic peptides presented by HLA‐B44 molecules on tumor cells expressing the gene MAGE‐3 by Fleischhauer, Katharina, Fruci, Doriana, van Endert, Peter, Herman, Jean, Tanzarella, Silvia, Wallny, Hans‐J., Coulie, Pierre, Bordignon, Claudio, Traversari, Catia

    Published in International journal of cancer (27-11-1996)
    “…The amino acid sequence of the protein encoded by the gene MAGE‐3was screened for peptides containing the binding motif for HLA‐B44. Nine peptides were…”
    Get full text
    Journal Article
  10. 10
  11. 11